Tool 'Berlion' Instruction for use

The drug "Berlithion" is considered to be quite effective (according to patients' reviews) a means regulating metabolic processes. The drug is often prescribed courses in conjunction with vitamin B1.

The drug "Berlition" has an antioxidant effect. It regulates lipid and carbohydrate metabolism, is a hepatoprotector. The active component is thioctic (alpha-lipoic) acid.

After oral intake (inside), the active substance is quickly absorbed from the digestive tract. Excretion is carried out in the form of decay products and unchanged in urine.

The tool "Berlion" instructions for use recommends for polyneuropathy diabetic and alcoholic.

Recommended dosage for adults inside - from three hundred to six hundred milligrams. You can take one or two meals.

With polyneuropathy in severe form, treatment with intravenous injection of the drug "Berlion" begins. Dosage at the same time - twelve to twenty-four milliliters per day. Duration of treatment - from two to four weeks. The subsequent therapy is carried out using a tablet form. Dosage at the same time - 300 mg once a day.

When intramuscular injection dosage in one place of administration should not be more than fifty milligrams (two milliliters). If it is necessary to use high doses of "Berlion", the instruction for use recommends that the amount be distributed to several injections (two milliliters per each injection site).

A medication can cause various negative manifestations. Among the adverse reactions from taking the "Berlion" remedy, the instruction for use marks the development of a feeling of heaviness in the head, difficulty breathing. As a rule, these reactions are a consequence of rapid intravenous administration. As practice shows, these manifestations are eliminated on their own.

In some cases, after the introduction of a vein, convulsions and diplopia, thrombocytopathy, hypoglycemia were noted. As local manifestations, the "Berlition" remedy can cause eczema or hives. In rare cases, there were reactions of a systemic nature (anaphylactic shock included).

To the contraindications to the prescription of the drug "Berlition" instructions for use include hypersensitivity.

Due to the lack of information on the effectiveness and safety of use of the drug by pregnant and lactating women, as well as children, these categories of patients, it is not assigned.

As shown by clinical studies, the active substance of the drug "Berlition" - thioctic acid - is highly effective in cardiovascular manifestations of diabetic polyneuropathy for patients with type 2 diabetes mellitus. The therapeutic efficacy of the medication in this category of patients may be due to the ability of the active component to affect the nervous vegetative system by increasing in particular the wave propagation velocity in visceral sympathetic and parasympathetic fibers.

Cases of overdose means "Berlition" clinical practice does not describe.

Interaction with other medicines.

It has been established that alpha-lipoic acid (thioktic acid) reacts with complexes including metal ions (with Cisplatin, for example). In this regard, with the simultaneous administration of the drug "Berlition" with the drug "Cisplastin", the effect of the former may weaken.

The component ethanol and its decomposition products when combined are also capable of reducing the effectiveness of thiectic acid.

Before using the "Berlition", you should carefully study the annotation.